Alex Scheepers

Title: Alex Scheepers: Innovator in Blood Product Separation

Introduction

Alex Scheepers is a notable inventor based in Sollentuna, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of blood product separation. His innovative methods have the potential to enhance the efficiency and effectiveness of blood treatment processes.

Latest Patents

Alex Scheepers holds a patent for a method of separating Factor VIII from blood products. This invention provides a method for isolating a Factor VIII (FVIII) protein from a composition that includes both the FVIII protein and a von-Willebrand-Factor (vWF) protein. The method involves contacting the first composition with an affinity resin that has a ligand with an affinity to the light chain of FVIII. This process allows for the separation of the FVIII protein from the vWF protein, resulting in a modified first composition and a second composition containing the affinity resin and the complex of the FVIII protein and the vWF protein. He has 1 patent to his name.

Career Highlights

Alex Scheepers is currently associated with Octapharma AG, a company known for its focus on human proteins and innovative therapies. His work at Octapharma AG has positioned him as a key player in the development of advanced blood treatment technologies.

Collaborations

Throughout his career, Alex has collaborated with talented professionals, including Stefan Winge and Per Rosen. These collaborations have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Alex Scheepers is a pioneering inventor whose work in the separation of Factor VIII from blood products showcases his commitment to improving medical technologies. His contributions are vital to the ongoing advancements in biotechnology and blood treatment.